![](https://investorshub.advfn.com/uicon/626250.png?cb=1543790799)
Tuesday, October 02, 2018 2:27:09 PM
There is plenty of talk about companies like Merck, Novartis and Pfizer looking to grab small medical cannabis companies as they are currently behind in the race. In fact they must now watch out for "mid-major" pharma like GW that has a head start in the cannabis sector.
So Merck is a possibility. JV? buyout? Who knows? Could also explain why Dr Dalton said he can't talk about the plan due to "legal reasons". Sounds like an NDA is possibly in place. If it was just an in house project he would be able to tell shareholders all about it. If we are working with big Pharma an NDA would certainly explain those legal restrictions imho.
#PRESCRIPTIONCANNABIS
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM
Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM
POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • POET • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM